GlassScriptPhysician profile
Elisabeth A Ferlic
NPI 1114185634
$3,149.85
in general payments reported to CMS, 2019-2025
14 companies · $94.49 in 2025
The $94.49 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $385 · 2021: $372 · 2022: $363 · 2023: $484 · 2024: $1,092 · 2025: $94.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $956 · Travel and Lodging: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $956.14 |
| Travel and Lodging | $713.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,322.02 | 2019-2025 | Rezum Generator, Lithoclast, Lynx System |
| Bluewind Medical | $821.50 | 2024 | Revi |
| Intuitive Surgical, INC. | $419.13 | 2020-2023 | |
| Laborie Medical Technologies Corp. | $111.73 | 2023 | |
| 180 Medical, INC. | $100.92 | 2020-2024 | |
| Medtronic, INC. | $85.09 | 2022-2024 | Interstim |
| Astellas Pharma US INC | $78.43 | 2019 | |
| Coloplast Corp | $75.58 | 2025 | |
| Convatec INC. | $40.64 | 2021 | |
| Ambu INC. | $28.00 | 2023 | |
| Medtronic USA, INC. | $24.02 | 2019 | |
| Axonics, INC. | $17.63 | 2023 | Bulkamid |
| Teleflex LLC | $17.16 | 2023 | Urolift |
| Travere Therapeutics, INC. | $8.00 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elisabeth Ferlic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.